Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study Group.
Carpenter PA, White L, McCowage GB, Nayanar V, Toogood I, Shaw PJ, Lockwood L, Tiedemann K. Carpenter PA, et al. Among authors: lockwood l. Cancer. 1997 Aug 1;80(3):489-96. doi: 10.1002/(sici)1097-0142(19970801)80:3<489::aid-cncr17>3.0.co;2-t. Cancer. 1997. PMID: 9241083 Clinical Trial.
Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study Group.
McCowage GB, White L, Carpenter P, Lockwood L, Toogood I, Tiedemann K, Shaw PJ. McCowage GB, et al. Among authors: lockwood l. Med Pediatr Oncol. 1997 Aug;29(2):108-14. doi: 10.1002/(sici)1096-911x(199708)29:2<108::aid-mpo8>3.0.co;2-i. Med Pediatr Oncol. 1997. PMID: 9180912 Clinical Trial.
Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
van Dalen EC, Mulder RL, Suh E, Ehrhardt MJ, Aune GJ, Bardi E, Benson BJ, Bergler-Klein J, Chen MH, Frey E, Hennewig U, Lockwood L, Martinsson U, Muraca M, van der Pal H, Plummer C, Scheinemann K, Schindera C, Tonorezos ES, Wallace WH, Constine LS, Skinner R, Hudson MM, Kremer LCM, Levitt G, Mulrooney DA. van Dalen EC, et al. Among authors: lockwood l. Eur J Cancer. 2021 Oct;156:127-137. doi: 10.1016/j.ejca.2021.06.021. Epub 2021 Aug 24. Eur J Cancer. 2021. PMID: 34450551
Long-term health-related quality of life in young childhood cancer survivors and their parents.
Fardell JE, Wakefield CE, De Abreu Lourenco R, Signorelli C, McCarthy M, McLoone J, Osborn M, Gabriel M, Anazodo A, Alvaro F, Lockwood L, Walwyn T, Skeen J, Tillemans R, Cohn RJ; ANZCHOG Survivorship Group. Fardell JE, et al. Among authors: lockwood l. Pediatr Blood Cancer. 2021 Dec;68(12):e29398. doi: 10.1002/pbc.29398. Epub 2021 Oct 4. Pediatr Blood Cancer. 2021. PMID: 34606168
Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).
White L, Kellie S, Gray E, Toogood I, Waters K, Lockwood L, Macfarlane S, Johnston H. White L, et al. Among authors: lockwood l. J Pediatr Hematol Oncol. 1998 Mar-Apr;20(2):125-30. doi: 10.1097/00043426-199803000-00007. J Pediatr Hematol Oncol. 1998. PMID: 9544162 Clinical Trial.
97 results